ALUR — ALLURION TECHNOLOGIES, INC.

OTC · Health Care · Health Care Equipment & Supplies · CIK 1964979 ·
Last close
Market Cap
52W High
52W Low
ADV30
Next earnings
2026-08-12
Allurion Technologies Inc. focuses on developing a weight loss platform for overweight people in Spain, France, Turkey, and internationally. Its Allurion Program platform offers the Allurion Smart Capsule, a swallowable and procedure-less intragastric balloon for weight loss, and access to the Allurion Virtual Care Suite, a digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program. The company is headquartered in Natick, Massachusetts.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 2,947,000 1,229,000 -3,731,000 -6,095,000 13,995,000 5,056,000 91,905,000
Dec 2025 3,613,000 1,608,000 -6,294,000 -6,035,000 15,772,000 5,412,000 92,961,000
Sep 2025 2,658,000 1,304,000 -9,630,000 -11,884,000 18,141,000 6,136,000 101,069,000
Jun 2025 3,379,000 2,497,000 -6,952,000 -9,335,000 28,169,000 12,722,000 92,145,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-22,698,000
Investing CF
$0
Financing CF
$7,337,000
CapEx
$-72,000
Dividends Paid
Buybacks
EPS Diluted TTM
$-3.07
As of
2026-06-07

Balance + Analyst (yfinance extras)

Retained Earnings
$-257,057,000
Inventory
$2,061,000
Receivables
$3,475,000
ST Investments
EBIT TTM
$-31,528,000
Pretax Income TTM
$-33,348,000
Interest Exp TTM
$1,820,000
Analysts
2

Yahoo Snapshot (yfinance, live)

Total Revenue
$12,597,000
EBITDA
$-27,055,000
Free Cash Flow
$-13,369,750
Enterprise Value
$82,043,688
Total Cash
$5,056,000
Total Debt
$78,246,000
Shares Out
1,000,417
Trailing EPS
$-3.96
Book Value
$-5.20
ROE
ROA
-66.8%
Div Yield

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 15,230,000 -30,157,000 -28,755,000 15,772,000 92,961,000 -28,946,000
Dec 2024 32,110,000 -50,198,000 -7,198,000 32,813,000 110,791,000 -42,300,000
Dec 2023 53,467,000 -79,078,000 -82,817,000 71,712,000 143,009,000 -63,982,000
Dec 2022 64,211,000 -32,010,000 -37,744,000 51,370,000 83,684,000 -46,981,000
Dec 2021

TTM Snapshot

Revenues TTM
NetIncome TTM
OpCashFlow TTM
Assets (Latest)
Forward EPS
$-1.24

Peers — same industry

TickerNameMarket CapLastDaily %
ISRG INTUITIVE SURGICAL INC $144.07B $406.78
SYK STRYKER CORP $126.42B $329.78
MDT Medtronic plc $107.36B $83.87
MMM 3M CO $82.16B $157.52
BSX BOSTON SCIENTIFIC CORP $66.54B $44.77

News headlines (Yahoo Finance, 1h cache)

Allurion Advances Plan to Re-List
2026-06-17 20:05 · Yahoo
Allurion Announces Strong Start to U.S. Launch with Exceptional Early Outcomes and Growth Momentum
2026-06-02 13:00 · Yahoo
Are Medical Stocks Lagging Allurion Technologies, Inc. (ALUR) This Year?
2026-02-27 14:40 · Yahoo
Zacks Industry Outlook Highlights Boston Scientific, Insulet, BioLife Solutions and Allurion
2025-11-18 09:01 · Yahoo
4 Medical Product Stocks to Watch From a Challenging Industry
2025-11-17 14:20 · Yahoo
Allurion Technologies Inc. Q3 2025 Earnings Call Summary
2025-11-13 13:30 · Yahoo
Allurion Technologies Inc (ALUR) Q3 2025 Earnings Call Highlights: Strategic Restructuring and ...
2025-11-12 21:04 · Yahoo
Allurion Technologies, Inc. (ALUR) Reports Q2 Loss, Misses Revenue Estimates
2025-08-19 22:40 · Yahoo
Allurion Technologies Inc (ALUR) Q2 2025 Earnings Call Highlights: Strategic Pivot and Cost ...
2025-08-14 07:08 · Yahoo
BioLife Solutions, Inc. (BLFS) Reports Break-Even Earnings for Q2
2025-08-07 21:20 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.